Desvenlafaxine NDC 0591-3660

NDC codes

FDA NDC Directory

Product NDC (as listed)0591-3660Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00591-3660Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0591-3660-30	00591366030	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3660-30)Marketed from Mar 1, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desvenlafaxine
Generic name (nonproprietary): desvenlafaxine
Active ingredients: Desvenlafaxine succinate — 100 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Actavis Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204065
Marketing start: Mar 1, 2017
Marketing end: Jan 31, 2027
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 0591-3660_f5e72c18-96f8-4538-a238-8c72138bd6ceSPL ID f5e72c18-96f8-4538-a238-8c72138bd6ceSPL set ID 617476f9-62d7-40ef-a1b1-c349d4ad706fRxCUI 1607617, 1874553, 1874559UNII ZB22ENF0XR
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400591366030 followed by a unit qualifier and the quantity

Package 00591-3660-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies ( 14 )] . Desvenlafaxine extended-release tablets are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204065

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204065
Product	Strength	Form · route	Labeler	Product NDC
Desvenlafaxine	Desvenlafaxine succinate 50 mg/1	Tablet, Extended releaseOral	Actavis Pharma, Inc.	0591-3659
Desvenlafaxine	Desvenlafaxine succinate 25 mg/1	Tablet, Extended releaseOral	Actavis Pharma, Inc.	0591-4060